Retrospective Study
Copyright ©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1429-1440
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Table 4 Clinical characteristics between “dual etiology” group and “hepatitis B virus alone” group before and after propensity score matching for age and sex
CharacteristicBefore PSM
After PSM
Dual etiology,
n = 755
HBV alone, n = 1373
P value
Dual etiology,
n = 755
HBV alone, n = 755
P value
Age, year53.83 ± 9.6253.87 ± 9.720.932 53.83 ± 9.6253.80 ± 9.580.957
Male324 (42.91)451 (32.85)< 0.001324 (42.91)324 (42.91)> 0.999
BMI, kg/m226.25 ± 3.6923.00 ± 3.07< 0.00126.25 ± 3.6923.05 ± 3.09< 0.001
Body fat %31.32 ± 7.6627.20 ± 7.27< 0.00131.32 ± 7.6626.04 ± 7.60< 0.001
WC, cm88.76 ± 10.4180.24 ± 8.88< 0.00188.76 ± 10.4180.45 ± 8.87< 0.001
Metabolic parameters
Diabetes135 (17.88)69 (5.03)< 0.001135 (17.88)41 (5.43)< 0.001
Hypertension153 (20.26)140 (10.20)< 0.001153 (20.26)81 (10.73)< 0.001
Hyperlipidemia93 (12.32)89 (6.48)< 0.00193 (12.32)58 (7.68)0.003
Glucose, mg/dL102 (26.32)93 (16.97)< 0.001102 (26.32)94 (20.10)< 0.001
HbA1c, %6.11 ± 1.065.68 ± 0.62< 0.0016.11 ± 1.065.69 ± 0.70< 0.001
TG, mg/dL139.82 ± 96.0090.08 ± 50.25< 0.001139.82 ± 96.0091.52 ± 51.42< 0.001
CHO, mg/dL196.49 ± 38.11193.06 ± 34.350.040 196.49 ± 38.11193.44 ± 34.530.104
HDL, mg/dL49.71 ± 11.5558.27 ± 13.73< 0.00149.71 ± 11.5557.96 ± 13.89< 0.001
LDL, mg/dL123.25 ± 33.16116.55 ± 29.91< 0.001123.25 ± 33.16117.00 ± 30.02< 0.001
Liver parameters
AST, U/L28.70 ± 13.2727.56 ± 16.690.084 28.70 ± 13.2728.10 ± 15.930.426
ALT, U/L33.40 ± 26.1625.91 ± 31.13< 0.00133.40 ± 26.1627.29 ± 34.92< 0.001
GGT, U/L24.21 ± 16.7417.73 ± 20.46< 0.00124.21 ± 16.7418.88 ± 23.99< 0.001
Fatty liver index37.72 ± 23.6615.09 ± 15.64< 0.00137.72 ± 23.6615.85 ± 16.07< 0.001
FIB-41.35 ± 0.641.57 ± 0.80< 0.0011.35 ± 0.641.61 ± 0.78< 0.001
FIB-4 > 2100 (13.25)307 (22.36)< 0.0001100 (13.25)185 (24.50)< 0.001
Other parameters
Carotid plaque198 (26.23)335 (24.40)0.352 198 (26.23)194 (25.70)0.814